FINERENONE IN CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES: A FIDELITY ANALYSIS OF LEFT VENTRICULAR HYPERTROPHY

• Main Authors: Luis Matavelli (Author), Gerasimos Filippatos (Author), Stefan D. Anker (Author), George L. Bakris (Author), Peter Rossing (Author), Luis M. Ruilope (Author), Luke Roberts (Author), Meike Brinker (Author), Alfredo Farjat (Author), Bertram Pitt (Author)
• Format: Book
• Published: Elsevier, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Therapeutic Area: Kidney Disease Background: Left ventricular hypertrophy (LVH) is a predictor of cardiovascular (CV) disease and associated morbidity and mortality. Patients with chronic kidney disease (CKD), type 2 diabetes (T2D) have a higher prevalence of LVH. In this exploratory analysis we inv...